CD274 and cancer: Different pathways such as myocarditis, pre-existing cardiovascular diseases, past cardiotoxic chemotherapy, uncommon myocardial metastases, old age, and systemic inflammatory conditions could contribute to arrhythmia in cancer patients treated with PD-1/PDL-1 inhibitors.